Publikace
- Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study2012 | 2. lékařská fakulta
- Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis2012 | 2. lékařská fakulta
- Electrophysiologic correlations with clinical outcomes in CIDP2010 | 2. lékařská fakulta
- Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study2010 | 2. lékařská fakulta
- A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis2010 | 2. lékařská fakulta
- Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | 2. lékařská fakulta
- Intravenous immunoglobulin in relapsing-remitting multiple sclerosis - A dose-finding trial2008 | 2. lékařská fakulta
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | 2. lékařská fakulta
- Repeated subcutaneous injections of IL12/23 P40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study2008 | 2. lékařská fakulta
- Is pregnancy in MS patients safe and what is its impact on MS course? Real World evidence of 1533 pregnancies in Czech Republic2022 | 1. lékařská fakulta, 2. lékařská fakulta, 3. lékařská fakulta, Lékařská fakulta v Hradci Králové, Lékařská fakulta v Plzni
Loading network view...